Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended, 10% Owner at Better Therapeutics, Inc. (BTTX), bought 1,000 shares at $5.98 ($6K) on 2021-12-10, disclosed to the SEC on 2021-12-14.
Open-market purchase of $6k BTTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BTTX | BUY | 2021-12-17 | $4K | — | Filing → |
| BTTX | BUY | 2021-12-06 | $7K | — | Filing → |